Enhancing the efficacy of immunotherapy in lung cancer

Enhancing the efficacy of immunotherapy in lung cancer

Biopharma Enhancing the efficacy of immunotherapy in non-small cell lung cancer using an RGD-mimetic   Queen Mary scientists led by Prof Kairbaan Hodivala-Dilke have invented a new methodology for treating lung cancer – the leading cause of cancer deaths...
A Combination Therapy for Neovascular Eye Diseases

A Combination Therapy for Neovascular Eye Diseases

Biopharma A Combination Therapy for Neovascular Eye Diseases   Angiogenesis is a leading cause of eye problems among over 50s – including blindness. Conventional treatments have serious side effects, making them deeply unpleasant for patients. A new peptide...
Diagnosing type 1 diabetes using insulin neoepitopes

Diagnosing type 1 diabetes using insulin neoepitopes

Biopharma Diagnosing type 1 diabetes using insulin neoepitopes   Diabetes is one of the most common chronic diseases in Britain – and is getting ever more prevalent. Although less than one in ten diabetes patients have type 1 diabetes, it is much more common among...
Reversing tumour resistance to kinase inhibitors

Reversing tumour resistance to kinase inhibitors

Biopharma Reversing tumour resistance to kinase inhibitors   Drug resistance is behind most relapses in cancer patients. This is partly why anti-cancer drugs targeting oncogenic kinase signalling have failed to live up to expectations. Kinase inhibitors are only...
Restorative treatments for osteoarthritis

Restorative treatments for osteoarthritis

Biopharma Restorative treatments for osteoarthritis   There’s no cure for osteoarthritis. Current treatment for this debilitating joint disease involves managing symptoms and replacing joints. Professor Francesco Dell’Accio and his team have invented three novel and...